GHGuo-Ying Huang

Guo-Ying Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Guo-Ying Huang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • B. Bin Qiao

    Institute of Cardiovascular Disease General Hospital of Jinan Military Region, Jinan , China

    1 shared publication
  • Bing Jia

    Children’s Hospital of Fudan University, Shanghai, China

    1 shared publication
  • Chen-Qi Lu

    Institute of Biostatistics, School of Life Sciences , Fudan University , Shanghai , China

    1 shared publication
  • Hong-Bing Shen

    Department of Epidemiology and Biostatistics, School of Public Health , Nanjing Medical University , Nanjing , China

    1 shared publication
  • Hongyan Wang

    Fudan University

    1 shared publication
  • Jian-Yuan Zhao

    Institute for Developmental and Regenerative Cardiovascular Medicine, MOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai 200092

    1 shared publication

Latest Publications

  • Open Access

    Genetic variants reducing MTR gene expression increase the risk of congenital heart disease in Han Chinese populations

    by Jian-Yuan Zhao, B. Bin Qiao, Wen-Yuan Duan, Xiao-Hong Gong, Qian-Qian Peng, Song-Shan Jiang, Chen-Qi Lu, Yi-Jiang Chen, Hong-Bing Shen, Guo-Ying Huang, et al.

    Elevated homocysteine levels are known to be a risk factor for congenital heart disease (CHD), but the mechanism underlying this effect is unknown. During early embryonic development, homocysteine removal is dictated exclusively by the MTR activity. To examine the role of MTR in CHD risk, we identified genetic variants in MTR and investigated the mechanisms that affect its expression levels and that increase the risk of CHD in Chinese populations. The association between regulatory variants of the MTR gene and CHD was examined in three independent case–control studies in a total of 2340 patients with CHD and 2270 controls. The functional consequences of these variants were demonstrated using dual-luciferase assays, real-time polymerase chain reaction (PCR), electrophoretic mobility shift assays, surface plasma resonance, chromatin immunoprecipitation, and bisulfite sequencing, as well as by a group of predicted microRNAs using a gene reporter system. Two regulatory variants of MTR, −186T>G and +905G>A, were associated with an increased risk of CHD in both the separate and combined case–control studies (−186GG P = 1.32 × 10−9; +905AA P = 6.35 × 10−14). Compared with the major allele, the −186G allele exhibited significantly lower promoter activity, decreased hnRNA and mRNA levels, reduced transcription factor binding affinity, and a more highly methylated promoter. The +905A allele exhibited a statistically stronger binding affinity to functional microRNAs that down regulate MTR expression at the translational level. Both of the minor alleles were correlated with elevated plasma homocysteine concentrations, indicating a genetic component for hyperhomocysteinaemia. Regulatory variants of the MTR gene increase CHD risk by reducing MTR expression and inducing the homocysteine accumulation and elevation.


  • Atypical Shone’s Complex Diagnosed by Echocardiography

    by Xiao-Jing Ma, Guo-Ying Huang, Xue-Cun Liang, Xiao-Qin Liu, Bing Jia

    Shone’s complex is a rare and severe type of congenital left-sided obstructive lesion of multiple cardiovascular levels. This report aims to present the authors’ experience diagnosing atypical Shone’s complex using echocardiography. Atypical Shone’s complex was diagnosed for 38 consecutive patients (18 boys and 20 girls, ages 1 day to 15 years) using echocardiography. All the diagnoses were confirmed by cardioangiography, surgery, or both. Among the congenital left-sided obstructive lesions, four levels of obstruction coexisted in 3 cases (7.9%), three levels in 10 cases (26.3%), and two levels in 25 cases (65.8%). Supra-annular mitral stenosis caused by a supravalvular mitral ring was diagnosed in 1 case. Mitral valvular stenosis was diagnosed in 24 cases including a parachute mitral valve (4 cases), a double-orifice mitral valve (1 case), and partly fused thickened mitral valvular leaflets (19 cases). Subaortic stenosis was diagnosed in 10 cases including circumferential membranous subaortic stenosis (1 case), tunnel-type subaortic narrowing (2 cases), and asymmetric obstructive fibrous ridge below the aortic valve (7 cases). Aortic stenosis was diagnosed in 25 cases including the bicuspid aortic valve (12 cases), the hypoplasia aortic annulus (3 cases), and partly fused or thickened tri-leaflet aortic valves (10 cases). Supra-aortic stenosis was diagnosed in 6 cases including the localized type (4 cases) and the diffused type (2 cases). Coarctation of the aorta was diagnosed in 26 cases. Of these, focal coarctation was described in 15 cases, long segment coarctation in 7 cases, and dysplastic isthmus and/or descending aorta in 4 cases. Secondary changes in Shone’s complex manifested as left atrial dilation (26 cases), left ventricular hypertrophy (26 cases), and pulmonary hypertension (19 cases). Echocardiography plays an important role in the diagnosis of atypical Shone’s complex, in comprehensive evaluation of the number, position, morphology, and severity of left-sided obstructions.